CLOVER BIO-B(02197),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02197 CLOVER BIO-B

Not Yet Opened 01-30 16:08:02

2.250

-0.020

-0.88%

High2.290	Low2.170	Vol3.05M
Open2.270	D1 Closing2.270	Amplitude5.29%
Mkt Cap2.92B	Tradable Cap2.92B	Total Shares1.30B
T/O6.79M	T/O Rate0.23%	Tradable Shares1.30B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"CLOVER BIO-B","latestPrice":2.25,"timestamp":1769760482346,"preClose":2.27,"halted":0,"volume":3050000,"delay":0,"changeRate":-0.008810572687224677,"floatShares":1298000000,"shares":1298000000,"eps":-0.8088585039837525,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"01-30 16:08:02","open":2.27,"high":2.29,"low":2.17,"amount":6790485,"amplitude":0.052863,"askPrice":2.26,"askSize":500,"bidPrice":2.25,"bidSize":5500,"shortable":0,"etf":0,"ttmEps":-0.8120922588267456,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":0,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":2.27,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":0.7642483710136528,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"1151479730","title":"Zaozhuang Mobile Innovatively Builds \"Clover\" Ideological and Political Work Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1151479730","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151479730?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:50","pubTimestamp":1769475050,"startTime":"0","endTime":"0","summary":"For a long time, the Party Committee of Zaozhuang Mobile in Shandong has actively explored and constructed a \"Clover\" ideological and political work model that integrates the three functions of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02197"],"gpt_icon":0},{"id":"1155208584","title":"CLOVER BIO-B (02197) Initiates Phase 2 Clinical Trial for RSV-hMPV-PIV3 Respiratory Combination Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1155208584","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155208584?lang=en_us&edition=fundamental","pubTime":"2026-01-12 12:38","pubTimestamp":1768192708,"startTime":"0","endTime":"0","summary":"CLOVER BIO-B (02197) announced that its self-developed Pre-F trimer subunit recombinant protein respiratory combination vaccine candidates, SCB-1022 (RSV+hMPV) and SCB-1033 (RSV+hMPV+PIV3), developed...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2602598859","title":"Clover Initiates Phase 2 Clinical Trial for Rsv + Hmpv ± Piv3 Respiratory Combination Vaccine Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2602598859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602598859?lang=en_us&edition=fundamental","pubTime":"2026-01-12 12:34","pubTimestamp":1768192447,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA34QKQK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2602560744","title":"Clover Biopharmaceuticals Launches Phase 2 Trial for RSV-hMPV-PIV3 Combination Vaccine Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2602560744","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602560744?lang=en_us&edition=fundamental","pubTime":"2026-01-12 12:27","pubTimestamp":1768192059,"startTime":"0","endTime":"0","summary":"Clover Biopharmaceuticals Ltd. has announced the initiation of a Phase 2 clinical trial in Australia to evaluate its protein-based respiratory combination vaccine candidates, SCB-1022  and SCB-1033 . The randomized, observer-blinded, multi-center study will enroll up to 420 older adults aged 60 to 85 years. Participants will receive either SCB-1022, SCB-1033, or a placebo. The trial will assess safety, reactogenicity, and immunogenicity of the vaccine candidates. Results from this study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Biopharmaceuticals Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLbsLGVy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2601824517","title":"Clover Biopharmaceuticals, Ltd.'s (HKG:2197) market cap rose HK$311m last week; retail investors who hold 53% profited and so did insiders","url":"https://stock-news.laohu8.com/highlight/detail?id=2601824517","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601824517?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:30","pubTimestamp":1767749452,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Clover Biopharmaceuticals by retail investors implies that the general public has...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2197/clover-biopharmaceuticals-shares/news/clover-biopharmaceuticals-ltds-hkg2197-market-cap-rose-hk311","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2197/clover-biopharmaceuticals-shares/news/clover-biopharmaceuticals-ltds-hkg2197-market-cap-rose-hk311","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","00656","BK1183","02889","LU0417516571.SGD","LU0823426480.USD","SG9999001093.SGD","LU1868837722.USD","LU0620787316.HKD","06138","LU0541501648.USD","01333","LU0231483743.USD","LU0509642566.USD","SG9999002828.SGD","BK1591","LU0345775950.USD","BK1144","LU1634259391.SGD","02150","LU0488056044.USD","03145","09923","LU0868486357.SGD","LU1282649067.USD","02315","LU0315178854.USD","BK1520","03800","LU0456846285.SGD","LU1366334651.USD","LU0634319403.HKD","LU0531970944.HKD","06855","06168","BK1100","LU0149721374.USD","LU0289739343.SGD","BK1619","00302","BK1589","BK1215","IE0032431581.USD","02197","LU0269904917.USD","02886","BK1613","LU0072462343.USD","01458","BK1247","06100","LU0463099449.HKD","LU2153591404.USD","LU0431992006.USD","09636","BK1150","01378","LU0359201885.HKD","LU1497733557.USD","02142","LU0348783233.USD","BK1110","06862","LU1770036033.HKD","01117","LU0823038988.USD","LU0516422952.EUR","03650","LU2039709279.SGD","LU0320764599.SGD","02145","01530","BK1228","LU1807302812.USD","00382","BK1119","BK1178","LU2424517915.HKD","02392","IE0009570106.USD","09880","01177","09959","LU1267930227.SGD","BK1559","BK1164","LU0640798160.USD","BK1615","00666","BK1595","SG9999000475.SGD","IE00BZ08YS42.EUR","BK1188","LU1634259557.SGD","LU0229945570.USD","SG9999011746.SGD","LU0049112450.USD","HK0000306685.HKD","00999","LU2008162690.USD","LU1880383440.USD","BK1554","SG9999001226.SGD","LU0261950983.USD","00826","LU0449515922.USD","80992","LU1211504680.USD","BK1541","SG9999006597.SGD","LU0082770016.SGD","06988","LU0791591158.USD","01818","BK1142","02157","02096","IE00BZ08YT58.USD","IE00BYV24P56.USD","LU1039395188.USD","002594","LU0329678337.USD","SG9999001069.SGD","02177","IE00BQXX3C00.GBP","SGXZ86797644.SGD","BK1141","LU0348767384.USD","LU0264606111.USD","02587","02256","02250","HK0000320264.USD","IE0008369823.USD","00699","LU0164872284.USD","BK1175","IE0003851619.USD","LU0039217434.USD","LU0348805143.USD","IE00B5MMRT66.SGD","LU2357125470.USD","BK1556","BK1521","LU1497734951.SGD","IE00B0169L03.USD","BK1219","SG9999004311.SGD","LU0737861699.HKD","LU2778985437.USD","BK1104","00451","LU0819123356.HKD","LU0828237510.HKD","02105","LU2506951792.HKD","LU1303224171.USD","01600","01783","LU2023250504.SGD","BK1582","HK0000500386.USD","BYDDY","00884","00384","IE00BQXX3F31.USD","LU0499858438.USD","LU1808992512.USD","02018","00003","03738","LU0572944931.SGD","02670","LU2476274720.SGD","BK1240","02431","06060","00992","LU2177674079.SGD","BK1128","BK1207","LU0572940350.SGD","BK1193","BK1179","LU1102505762.USD","03998","BK1592","BK1587","BK1167","LU1720050803.USD","09890","LU0516423174.USD","01471","IE00BGV7N243.SGD","09961","BK1596","00017","LU0143863198.USD","01809","LU2328871848.SGD","BK1132","LU0052756011.USD","SG9999003461.SGD","02420","LU2360107325.USD","01440","02331","BK1198","BK1607","LU0499858602.USD","02382","LU0327786744.USD","SG9999006514.SGD","BK1171","02567","BK1544","BK1593","LU0865486749.SGD","BK1512","IE00BVYPNP33.GBP","LU0502904849.HKD","01448","01384","LU0067412154.USD","LU1366334578.USD","BK1604","BK1160","BK1190","LU0828238088.HKD","01520","LU0082770016.USD","BK1550","00363","LU1831875114.USD","00855","LU1481107354.HKD","02696","03681","HYDD.SI","BK1227","06919","BK1117","BK1606","LU0823437842.USD","00267","BK1542","BK1609","LU0289961442.SGD","BK1564","BK1579","82331","09878","LU0823039010.USD","06618","LU0315179316.USD","BK1200","02533","BK1186","LU0572939691.SGD","LU0289960550.SGD","01405","BK1553","HK0000165453.HKD","LU0054450605.USD","LU0261950470.USD","LU0128525689.USD","LU0823414478.USD","IE00BD6J9T35.USD","BK1131","IE00B543WZ88.USD","BK1148","SGXZ62798434.SGD","BK1574","IE00BMCWC346.EUR","LU2097828631.EUR","LU0593848301.USD","LU1522347837.USD","SG9999001051.SGD","02469","LNNGY","09956","LU0259732245.USD","02298","02858","00020","LU0505663152.USD","LU0054237671.USD","LU0449509016.USD","LU0594300179.USD","01969","LU0228659784.USD","LU0831093199.SGD","01762","LU0762540952.USD","BK1597","BK1598","BK1147","BK1235","IE00B8L5B284.USD","02013","SG9999000418.SGD","LU1226288253.USD","BK1216","06186","LU1981816686.USD","06058","BK1161","HK0000320223.HKD","BK1239","BK1500","BK1137","BK1214","BK1524","IE00B0JY6N72.USD","BK1257","LU0856984785.SGD","BK1229","00777","BK1225","02100","IE0031814852.USD","BK1518","LU0314109678.HKD","LU1960683339.HKD","LU0348735423.USD","00867","IE00B031J352.USD","09919","LU0871576103.HKD","06160","LU2249611893.SGD","LU2045819591.USD","86618","02616","LU1242518857.USD","LU0251144936.SGD","LU1152091754.HKD","BK1096","BK1116","BK1189","BK1566","01880","LU2488822045.USD","01877","03658","06090","02268","LU1152091168.USD","01119","02276","IE00BZ08YR35.GBP","LU1508157978.USD","06609","BK1143","06657","BK1575","LU1226287875.USD","03896","LU2399975544.HKD","BK1509","LU1328277881.USD","IE0034224299.USD","BK1237","09690","02436","BK1528","LU1048588211.SGD","LU2294711713.HKD","02228","LU1939255532.USD","BK1600","LU1974910355.USD","BK1212","LU2460026573.USD","BK1515","LU2663582299.SGD","BK1154","02411","LU0175139822.USD","BK1114","LU1951186391.HKD","LU0048580855.USD","BK1608","BK1571","SG9999014674.SGD","BK1555","06613","LU0307460666.USD","LU0261947096.USD","BK1230","LU0251143458.SGD","80020","BK1548","06963","LU0540923850.HKD","82020","BK1522","02380","06913","06683","LU0456827905.SGD","00512","LU0979878070.USD","BK1136","BK1519","LU0588545490.SGD","BK1125","02511","BK1209","LU1226287792.SGD","SG9999015945.SGD","LU0650527681.SGD","SG9999004220.SGD","BK1197","02453","LU1008478684.HKD","09678","LNVGY","BK1583","00300","BK1549","SG9999015952.SGD","LU1969619763.USD","09660","09926","LU2506952253.HKD","BK1527","81211","BK1258","01211","06633","BK1184","09911","BK1539","LU1961090484.USD","LU0329678170.USD","02556","BK1540","LU1251922891.USD","ANPDY","IE00B8HQ1Z84.USD","02595","BK1594","LU1917777945.USD","LU1956131251.USD","BK1526","LU2097828714.EUR","BK1195","BK1233","LU0287142896.SGD","LU0880133367.SGD","LU0819121731.USD","02627","09699","BK1504","LU0823397103.USD","LU0605514214.HKD","LU2298064838.USD","BK1617","BK1588","BK1126","LU0173614495.USD","LU1226287529.USD","SG9999002950.SGD","LU1023057109.AUD","BK1552","LU0211977185.USD","BK1577","02451","06996","LU0516422440.USD","SG9999002562.SGD","LU0543330566.HKD","01093","02590","02650","03396","02158","LU3063872942.SGD","LU2238339852.HKD","LU0516422366.SGD","03939","SGXZ90724238.SGD","LU0048597586.USD","09639","00305","BK1222","03709","BK1220","BK1530","LU0143863784.USD","02552","00960","01519","LU0348825331.USD","HK0000306701.USD","LU0072913022.USD","LU2242644610.SGD","LU0165289439.USD","BK1111","06069","BK1516","02525","BK1155","LU1880383366.USD","09955","BK1616","BK1134","02190","BK1109","LU0370786039.SGD","BK1169","02273","LU2348774022.SGD","01276","BK1194","BK1578","LU2106854487.HKD","LU2097828805.USD","09877","LU1166156734.SGD","BK1221","03680","00460","LU0417516902.SGD","LU1102505929.USD","01651","IE00BQXX3D17.EUR","06608","BK1191","BK1163","LU0594300419.USD","LU0823397285.USD","LU0516423091.SGD","SG9999001903.USD","LU2543165471.USD","LU0048575426.USD","LU2153592121.USD","01164","LU2449936058.SGD","BK1224","LU0737861772.HKD","LU0511384066.AUD","00136","SG9999015986.USD","LU2125910500.SGD","LU0051755006.USD","LU0244354667.USD","01070","LU2476274308.USD","LU0541502299.USD","SG9999015978.USD","IE00BGHQDM52.EUR","02460","LU0455707207.USD","LU0384037296.USD","01318","LU1794554557.SGD","01833","LU0310800965.SGD","LU0345776255.USD","BK1560","02419","01681","02488","IE00BVYPNQ40.USD","LU1861214812.USD","BK1610","HK0000252160.HKD","BK1124","BK1585","LU1993786604.SGD","LU0164865239.USD","00798","LU0326950275.SGD","09990","LU0107464264.USD","03836","BK1158","IE00B29SXG58.USD","LU0359201612.USD","BK1139","02506","09992","LU0274383008.USD","06821","HK0000252152.HKD","02629","BK1605","00875","IE00B031HY20.USD","02509","BK1168","00861","01640","LU0254981946.USD","02565","LU0531971595.HKD","LU1497733631.SGD","LU2097828557.USD","SG9999000459.SGD","02598","LU0214875030.USD","02279","BK1523","BK1253","LU2097828474.EUR","IE0003795394.USD","01907","01939","BK1151","IE0008368742.USD","LU0348766576.USD","LU1226288170.HKD","LU0052750758.USD","LU0588545904.SGD","01739","LU0561508036.HKD","LU0348784397.USD","LU0043850808.USD","IE00BPRC5H50.USD","LU1282649810.SGD","09860","BK1590","BK1618","LU1115378108.SGD","LU0164880469.USD","02020","BK1586","01911","01735","02171","06677","00135","LU0823426308.USD","LU1242518931.SGD","LU1770034418.SGD","LU0084288322.USD","09985","LU1046422090.SGD","06086","LU0011963245.USD","LU0823414551.USD","LU1868837565.USD","SG9999002463.SGD","LU0501845795.SGD","01952","LU1813983027.USD","03677","01773","BK1170","LU0140636845.USD","02155","LU0348827113.USD","LU0359202008.SGD","LU0702159699.USD","BK1127","LU0588546209.SGD","LU1224709979.USD","BK1140","LU1235295612.USD","BK1531","LU0164939612.USD","LU1868838027.USD","02057","02400","LU0417516738.SGD","BK1095","LU0791590937.USD","02167","BK1502","LU0588545730.USD","LU0469268626.HKD","LU0708995583.HKD","02498","LU0611395673.USD","LU2348773727.SGD","LU1719994722.HKD","BK1557","02551","09996","01585","09927","LU1861219969.SGD","LU1675838814.USD","LU1188198961.HKD","02121"],"gpt_icon":1},{"id":"1134111883","title":"Clover Biopharmaceuticals (02197) Announces Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1134111883","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134111883?lang=en_us&edition=fundamental","pubTime":"2025-11-05 17:45","pubTimestamp":1762335949,"startTime":"0","endTime":"0","summary":"During October 2025, Clover Biopharmaceuticals (02197) did not alter its authorized share capital, which remains at 2,000,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"gpt_icon":0},{"id":"1194589121","title":"Wang Xiaodong: 15th National Games to Help Guangzhou Become a City of Sports for All","url":"https://stock-news.laohu8.com/highlight/detail?id=1194589121","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194589121?lang=en_us&edition=fundamental","pubTime":"2025-10-28 07:31","pubTimestamp":1761607883,"startTime":"0","endTime":"0","summary":"With just over ten days left until the opening of the 15th National Games in Guangzhou, Wang Xiaodong, Chairman of Guangzhou Double Fish Sports Goods Group, revealed that this marks the fifth time...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2576001227","title":"Clover Biopharmaceuticals Appoints Nicholas Jackson as President of Global R&D and Alliances","url":"https://stock-news.laohu8.com/highlight/detail?id=2576001227","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576001227?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:00","pubTimestamp":1760914814,"startTime":"0","endTime":"0","summary":"Clover Biopharmaceuticals Ltd. has appointed Nicholas Jackson, Ph.D., as President of Global R&D and Alliances. Dr. Jackson will focus on advancing the company's RSV+hMPV±PIV3 combination vaccine candidates and leading potential global partnerships. He brings over 27 years of experience in vaccine and infectious disease research, with previous leadership roles at GSK, Pfizer, Sanofi, and the Novo Nordisk Foundation Initiative for Vaccines and Immunity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Biopharmaceuticals Ltd. published the original content used to generate this news brief via PR Newswire  on October 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251019:nNDLbdM4Sf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0225284248.USD","BK4568","IE00BLSP4239.USD","LU0289739699.SGD","LU1883839398.USD","02197","LU1057294990.SGD","BK4007","IE00BBT3K403.USD","BK4550","BK4599","LU1023059063.AUD","BK4533","LU1066053197.SGD","LU0306807586.USD","BK4581","LU1894683264.USD","LU0321505439.SGD","SG9999001176.USD","SG9999013999.USD","BK4588","LU0122379950.USD","SG9999011175.SGD","LU0985481810.HKD","LU0058720904.USD","LU0456855351.SGD","LU0225771236.USD","SG9999001176.SGD","LU0234572021.USD","BK1161","IE000M9KFDE8.USD","IE00B19Z3581.USD","BK4534","LU0170899867.USD","SG9999003800.SGD","BK4585","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999002224.SGD","SG9999002232.USD","LU0321505868.SGD","LU0306806265.USD","BK4592","IE00BLSP4452.SGD","LU1894683348.USD","IE0002270589.USD"],"gpt_icon":1},{"id":"2576509645","title":"Peng Liang Spends CN¥545k On Clover Biopharmaceuticals Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2576509645","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576509645?lang=en_us&edition=fundamental","pubTime":"2025-10-18 07:32","pubTimestamp":1760743969,"startTime":"0","endTime":"0","summary":"Even if it's not a huge purchase, we think it was good to see that Peng Liang, the Founder of Clover...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2197/clover-biopharmaceuticals-shares/news/peng-liang-spends-cn545k-on-clover-biopharmaceuticals-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2197/clover-biopharmaceuticals-shares/news/peng-liang-spends-cn545k-on-clover-biopharmaceuticals-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CN","02197","BK1161"],"gpt_icon":0},{"id":"1166800025","title":"Hong Kong Stock Alert | CLOVER BIO-B (02197) Opens Up Over 5% on Positive Preliminary Clinical Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1166800025","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166800025?lang=en_us&edition=fundamental","pubTime":"2025-10-15 09:34","pubTimestamp":1760492060,"startTime":"0","endTime":"0","summary":"CLOVER BIO-B (02197) opened significantly higher by over 5%. As of press time, the stock was up 5.67% to HK$2.98, with a trading volume of HK$1.3738 million. On the news front, Clover...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2575296949","title":"Clover Biopharmaceuticals Ltd - Increases in Neutralizing Antibodies Observed for Rsv, Hmpv, Piv3","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296949?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:19","pubTimestamp":1760437169,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUA4Z5JBQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02197","BK1161"],"gpt_icon":0},{"id":"2575296366","title":"Clover Announces Positive Phase I Clinical Data for Rsv-Hmpv-Piv3 Combination Vaccines and for Rsv Re-Vaccination in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296366?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:19","pubTimestamp":1760437169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUA4Z5JBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"2575159296","title":"Clover Biopharmaceuticals Ltd - Rsv+Hmpv±Piv3 Vaccine Candidates to Advance to Phase Ii Trials in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575159296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575159296?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:19","pubTimestamp":1760437169,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUA4Z5JBQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02197"],"gpt_icon":0},{"id":"1189980496","title":"CLOVER BIO-B (02197) Announces Positive Phase I Clinical Trial Data for Respiratory Combination Vaccine (RSV-hMPV-PIV3) and RSV Vaccine Booster in Elderly Population","url":"https://stock-news.laohu8.com/highlight/detail?id=1189980496","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189980496?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:16","pubTimestamp":1760436980,"startTime":"0","endTime":"0","summary":"CLOVER BIO-B (02197) announced positive preliminary data from two ongoing clinical trials based on the company's proprietary and fully validated Trimer-Tag vaccine development platform, evaluating...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","159646","02197"],"gpt_icon":0},{"id":"2575295780","title":"Clover Biopharmaceuticals Announces Positive Phase I Data for RSV-HMPV-PIV3 Combination Vaccines, Plans Phase II Trials in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575295780","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575295780?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:10","pubTimestamp":1760436615,"startTime":"0","endTime":"0","summary":"Clover Biopharmaceuticals Announces Positive Phase I Data for RSV-HMPV-PIV3 Combination Vaccines, Plans Phase II Trials in 2026. Clover Biopharmaceuticals Ltd. has announced positive preliminary Phase I clinical data for its combination respiratory PreF vaccine candidates targeting RSV, hMPV, and PIV3, utilizing its Trimer-Tag platform technology. The announcement covers results from two ongoing clinical trials: one in Australia evaluating SCB-1022  and SCB-1033  in older adults, and another in the U.S. assessing re-vaccination with SCB-1019 in individuals previously vaccinated with GSK's AREXVY. Based on these results, Clover intends to advance SCB-1022 and SCB-1033 to Phase II clinical trials in the first half of 2026. Additional data from the ongoing RSV re-vaccination trial is expected by the first half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL1CpmMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02197"],"gpt_icon":0},{"id":"1163204562","title":"Hong Kong Stock Alert | CLOVER BIO-B (02197) Surges Over 21% Following Announcement of Phase I Clinical Trial Launch for Respiratory Combination Vaccine Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1163204562","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163204562?lang=en_us&edition=fundamental","pubTime":"2025-10-02 11:36","pubTimestamp":1759376209,"startTime":"0","endTime":"0","summary":"CLOVER BIO-B (02197) surged over 21%, rising 21.15% to HK$2.75 with trading volume of HK$42.2186 million at the time of reporting. On the news front, in June this year, Clover Biopharmaceuticals...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07226","BK1161","02197","YANG","BK4614","HSCEI"],"gpt_icon":1},{"id":"1109948039","title":"HK Movers | Biotech Stocks Jump With Biocytogen up 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109948039","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109948039?lang=en_us&edition=fundamental","pubTime":"2025-09-18 10:20","pubTimestamp":1758162006,"startTime":"0","endTime":"0","summary":"Biotech stocks surged in Hong Kong. Biocytogen Pharmaceuticals rose 11%, Duality Biotherapeutics rose 5%, Clover Biopharmaceuticals and XtalPi Holdings rose 4%, RemeGen rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"7f57c21d2de1ad5f8126acab611ae5a5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","09606","09926","02315","02197","09995","06160"],"gpt_icon":0},{"id":"1165477251","title":"Biotech Stocks Rebound. Transthera up 16%; Hightide up 13%; Clover Bio up over 9%; Alphamab up 8%; Zai Lab, Jacobio up over 6%; Mirxes up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165477251","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165477251?lang=en_us&edition=fundamental","pubTime":"2025-09-12 09:48","pubTimestamp":1757641711,"startTime":"0","endTime":"0","summary":"Biotech stocks rebounded on Friday. Transthera up 16%; Hightide up 13%; Clover Bio up over 9%; Alphamab up 8%; Zai Lab, Jacobio up over 6%; Mirxes up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"dbb90568ab4fea5a8074bebd42fd3ce0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","02511","09688","02617","09966","01167"],"gpt_icon":0},{"id":"1145327614","title":"HK Movers | Biotech Stocks Plunge. Ascletis Pharma down 14%; Clover Bio, Transcenta down over 10%; Beigene, HBM Holdings down over 8%; Jacobio down over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145327614","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145327614?lang=en_us&edition=fundamental","pubTime":"2025-09-11 09:45","pubTimestamp":1757555109,"startTime":"0","endTime":"0","summary":"Biotech stocks plunged on Wednesday. Ascletis Pharma down 14%; Clover Bio, Transcenta down over 10%; Beigene, HBM Holdings down over 8%; Jacobio down over 7%.President Donald Trump told European...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"517f47f3ba9e22d696e0ed04315d9ab5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"US Reportedly Plans to Tighten Grip around US Pharma Firms' Licensing from CN Drug Firms","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","01672","01167","06628","09966","02197","02616"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cloverbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0625},{"period":"1month","weight":-0.0385},{"period":"3month","weight":0.0227},{"period":"6month","weight":3.1667},{"period":"1year","weight":9.3211},{"period":"ytd","weight":-0.0385}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Clover Biopharmaceuticals Ltd is an investment holding company primarily engaged in the research and development, manufacture and commercialization of innovative vaccines. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The Company leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.113925},{"month":2,"riseRate":0.5,"avgChangeRate":0.046184},{"month":3,"riseRate":0,"avgChangeRate":-0.222172},{"month":4,"riseRate":0.25,"avgChangeRate":-0.061289},{"month":5,"riseRate":0.5,"avgChangeRate":-0.108229},{"month":6,"riseRate":0.5,"avgChangeRate":0.010941},{"month":7,"riseRate":0.5,"avgChangeRate":0.152709},{"month":8,"riseRate":0.5,"avgChangeRate":0.089271},{"month":9,"riseRate":0.5,"avgChangeRate":0.326004},{"month":10,"riseRate":0,"avgChangeRate":-0.070872},{"month":11,"riseRate":0.75,"avgChangeRate":0.569272},{"month":12,"riseRate":0.2,"avgChangeRate":-0.160916}],"exchange":"SEHK","name":"CLOVER BIO-B","nameEN":"CLOVER BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CLOVER BIO-B(02197),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CLOVER BIO-B(02197) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CLOVER BIO-B,02197,CLOVER BIO-B股票,CLOVER BIO-B股票老虎,CLOVER BIO-B股票老虎国际,CLOVER BIO-B行情,CLOVER BIO-B股票行情,CLOVER BIO-B股价,CLOVER BIO-B股市,CLOVER BIO-B股票价格,CLOVER BIO-B股票交易,CLOVER BIO-B股票购买,CLOVER BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CLOVER BIO-B(02197),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CLOVER BIO-B(02197) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}